Richard Fitzgerald

Directeur/Membre du Conseil chez Bucknell University Alumni Association

Profil

Richard F.
Fitzgerald founded SIRPant Immunotherapeutics, Inc. in 2020, where he worked as Chief Financial Officer from 2020 to 2021.
Mr. Fitzgerald also currently works at Bucknell University Alumni Association, as Director, The American Institute of Certified Public Accountants, as Member, and Pennsylvania Institute of Certified Public Accountants, as Member.
Mr. Fitzgerald also formerly worked at Biotechnology Innovation Organization, as Co-Chairman, PECO Energy Co., as Director-Corporate Development in 2002, Exelon Corp., as Director-Corporate Development, Dillon Consulting Ltd., as Director, Nucleonics, Inc., as Chief Financial Officer & Vice President from 2002 to 2009, PricewaterhouseCoopers LLP, as Senior Manager-Audit & Transaction Services from 1985 to 1995, Techprecision Corp., as Chief Financial Officer & Head-Investor Relations from 2012 to 2015, 22nd Century Group, Inc., as Chief Financial Officer from 2021 to 2022, Immunome, Inc., as Chief Financial Officer in 2020, PAVmed, Inc., as Chief Financial Officer & Secretary from 2015 to 2017, Sesen Bio, Inc., as Chief Financial Officer & Treasurer in 2019, and CleanTech Acquisition Corp., as Chief Financial Officer.
Mr. Fitzgerald received his undergraduate degree from Bucknell University.

Postes actifs de Richard Fitzgerald

Sociétés	Poste	Début
The American Institute of Certified Public Accountants	Corporate Officer/Principal	08/11/2010
Pennsylvania Institute of Certified Public Accountants	Corporate Officer/Principal	08/11/2010
Bucknell University Alumni Association	Directeur/Membre du Conseil	-

Anciens postes connus de Richard Fitzgerald

Sociétés	Poste	Fin
22ND CENTURY GROUP, INC.	Directeur Financier/CFO	15/06/2022
SIRPant Immunotherapeutics, Inc.	Fondateur	01/02/2021
IMMUNOME, INC.	Directeur Financier/CFO	30/11/2020
CARISMA THERAPEUTICS, INC.	Directeur Financier/CFO	26/08/2019
PAVMED INC.	Directeur Financier/CFO	21/03/2017